As part of our Lecture Series, we are thrilled to announce that we are sponsoring an event featuring Christopher Pittenger, MD, PhD, director of the Yale OCD Research Clinic, as the keynote speaker. Dr. Pittenger will share his groundbreaking research on novel treatments for OCD, shedding light on the latest advancements in the field. He will also provide a comprehensive overview of the basics regarding OCD, treatment, medication, etc.
Dr. Pittenger, a renowned psychiatry researcher, is a leading figure in the field. He earned his MD and Ph.D. from Columbia University and later returned to Yale University, his undergraduate alma mater, for research and residency. Pittenger’s research focuses on the brain’s role in creating thought, feeling, and consciousness, as well as how brain dysregulation leads to mental suffering. His work has been particularly focused on OCD and Tourette syndrome, and the cortico-basal ganglia circuitry. He co-founded the Yale Program for Psychedelic Science, focusing on how molecules like psilocybin and LSD can teach us about brain and behavior, potentially leading to new treatments for neuropsychiatric pathology. Pittenger is a member of the Scientific Advisory Board of the International OCD Foundation and OCD Connecticut, and a Fellow of the American College of Neuropsychopharmacology, American Psychiatric Association, and American Neurological Association.
The event will take place on Tuesday, June 18, 2024, at 7:00 pm in the Cohen Auditorium located in the Yale Child Study Center, 230 S. Frontage Road NIHB E-02, New Haven, CT. For driving and parking directions to the Cohen Auditorium, click here.
Dr. Pittenger’s website is https://medicine.yale.edu/profile/christopher-pittenger/.
The Yale OCD Research Clinic website is https://medicine.yale.edu/psychiatry/ocd/.
If you are interested in attending, please RSVP to [email protected].